OptiBiotix Health plc (OPTI) Ord 2p
6.50p
(7.74%)
- Add to watchlist
- Create an alert
- This stock can be held in a
6.50p
(7.74%)
6.50p
(7.74%)
85.50p
93.70p
133.00p
£76.68 million
84.00p
86.65p
54.50p
34.57
2.50p (2.89%) Previous:
2.50p
347,978
n/a
7,500
Performance
Not available for this stock.
Fundamental data
| Year ending: | 30/11/2017 | 30/11/2016 |
|---|---|---|
| Revenue (£m) | 0.19 | 0.29 |
| Profit before tax (£m) | 1.69 | (1.52) |
| Adjusted EPS (p): | 2.43 | (1.67) |
| P/E ratio | 28.40 | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Open an easy to manage, low cost dealing account in less than 5 minutes
Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.
More about the Fund and Share AccountImportant Documents
There are no documents available for this stock.
Broker forecasts
-
Strong Sell
(0 of 1) -
Sell
(0 of 1) -
Neutral
(1 of 1) -
Buy
(0 of 1) -
Strong Buy
(0 of 1)
This is not a recommendation, it represents the consensus view of a basket of brokers. If fewer than 5 brokers it may not be a valid consensus. HL might not concur and takes no responsibility.
Full broker forecasts-
OptiBiotix's 'SlimBiome' granted medical device status and CE mark
27 November 2018 14:17
-
OptiBiotix signs distribution agreement for Greece and Cyprus
22 November 2018 16:00
-
OptiBiotix enters three-year distribution deal with Bulgarian partner
26 September 2018 13:47
-
SlimBiome Medical manufacturing agreement
29 November 2018 07:00
-
SlimBiome® granted medical device status & CE mark
27 November 2018 07:00
-
CholBiome® agreement for Greece and Cyprus
22 November 2018 07:00
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.